🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrew M. Brunner

Harvard University

ORCID: 0000-0002-2169-4115

Also affiliated with Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes”.

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.05.652090

N/A

0.106DataRank · unranked

1 citations

Mounica Vallurupalli, Sarah Noel, Gail Schor, YuhJong Liu, Celeste Nobrega +29 more

Coping strategies in patients with acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021005845

N/A

0DataRank · unranked

17 citations

Monica H. Bodd, Matthew Reynolds, Ashley M. Nelson, Richard Newcomb, P. Connor Johnson +13 more

SOHO State of the Art and Next Questions: Treatment of Higher-Risk Myelodysplastic Syndromes

Clinical Lymphoma Myeloma & Leukemia(2022)10.1016/j.clml.2022.07.012

N/A

0DataRank · unranked

6 citations

Andrew M. Brunner, Brandon J. Aubrey

The highs and lows of venetoclax with hypomethylating agents for refractory AML

Leukemia Research(2020)10.1016/j.leukres.2020.106320

N/A

0DataRank · unranked

0 citations

Andrew M. Brunner

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae067

N/A

0DataRank · unranked

12 citations

Andrew M. Brunner, Jesse J. Plascak, Hajime Uno, Juan C. Varela, Marlise R. Luskin +6 more

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes

American Journal of Hematology(2023)10.1002/ajh.27161

N/A

0DataRank · unranked

48 citations

Jordi Esteve, Kimmo Porkka, Steven Knapper, Elie Traer, Sebastian Scholl +22 more

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

0DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more